Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2000
08/09/2000CN1262678A Triazole compounds and use thereof as dopamine-D3-ligands
08/09/2000CN1262676A 吡啶衍生物 Pyridine derivatives
08/09/2000CN1262620A Beta-Alkoxyacrylates against malaria
08/09/2000CN1262272A HIV proteinase inhibitor
08/09/2000CN1262269A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
08/08/2000US6100292 Hemopoietic composition for treatment/prophylaxis of cytopenia
08/08/2000US6100291 Pyrrolidine-indole compounds having 5-HT6 affinity
08/08/2000US6100284 Antiallergens
08/08/2000US6100268 Vasoconstrictive dihydrobenzopyran derivatives
08/08/2000US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts
08/08/2000US6100265 Benzothiopyran and thienothiopyran derivatives; serotonin-2 blocking action; treatment of circulatory diseases in general such as hypertension, ischemic heart disease, cerebrovascular disturbance, and peripheral circulatory disturbance
08/08/2000US6100253 Tricycle substituted with azaheterocyclic carboxylic acids
08/08/2000US6100220 Pesticides and herbicides
08/08/2000CA2072575C Anticholinergic agents
08/08/2000CA2018438C Imidazolyl-alkenoic acids
08/08/2000CA2012661C Thienylpiperazines, process for the preparation thereof, the use thereof, and pharmaceuticals containing these and the preparation thereof
08/03/2000WO2000044743A1 Amide derivatives and drug compositions
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044726A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/02/2000EP1024138A1 Pyrazole derivatives
08/02/2000EP1023268A1 Isoquinolines as urokinase inhibitors
08/02/2000EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES
08/02/2000EP0731796B1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
08/02/2000EP0691953B1 1-amidinophenyl-pyrrolidones/ piperidinones as platelet aggregation inhibitors
08/02/2000CN1261884A Benzothiophene derivatives as herbicides
08/02/2000CN1261880A Inhibitors of farnesyl protein transferase
08/02/2000CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
08/01/2000US6096898 One pot synthesis of 1,2,4-triazoles
08/01/2000US6096897 Endothelin receptor antagonists
08/01/2000US6096895 Heterocyclic dihydrazole compounds and their use for controlling fungal plant diseases
08/01/2000US6096887 Certain fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
08/01/2000US6096840 Gas phase polymerization process
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096754 N-3 substituted pyrimidin-4-ones with AII antagonistic activity
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096745 Imidazolone anorectic agents: III. heteroaryl derivatives
08/01/2000US6096739 Treatment for CNS injuries
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors
08/01/2000US6096689 5-pyrazolylbenzoic acid derivatives as herbicides
07/2000
07/27/2000WO2000043393A1 Novel angiogenesis inhibitors
07/27/2000WO2000043390A1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043009A1 Pyridine compounds, use and preparation thereof
07/27/2000WO2000042849A1 COMPLEX OF RAS-FARNESYLTRANSFERASE INHIBITOR AND SULFOBUTYLETHER-7-β-CYCLODEXTRIN OR 2-HYDROXYPROPYL-β-CYCLODEXTRIN AND METHOD
07/27/2000WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation
07/27/2000WO2000020399A3 Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for the production thereof and agents containing the same
07/27/2000WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase
07/27/2000WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
07/27/2000CA2359680A1 Kinase inhibitors
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2356349A1 Novel angiogenesis inhibitors
07/26/2000EP1021441A1 Substituted 2,4-diamino-1,3,5-triazine and their use as herbicides
07/26/2000EP1021440A2 Antipsychotic substituted piperidine derivatives
07/26/2000EP1021437A1 Arylsulfonylimidazolone derivatives as an antitumor agent
07/26/2000EP1021417A1 Substituted phenyluracils
07/26/2000EP1021415A1 Tricyclic aminoalkylcarboxamides; novel dopamine d 3? receptor subtype specific ligands
07/26/2000EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/26/2000EP1021410A1 Prostaglandin agonists and their use to treat bone disorders
07/26/2000EP1021405A1 Azetidinone derivatives for the treatment of hcmv infections
07/26/2000EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
07/26/2000EP1021173A1 Use of csaid?tm compounds for the management of uterine contractions
07/26/2000EP0736011B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
07/26/2000EP0694032B1 Method for preparing beta-lactams
07/26/2000CN1261350A Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
07/26/2000CN1261348A Dihydropyridine derivatives
07/26/2000CN1261072A 7-halogenated and 7 beta, 8 beta-methylene-taxinol, its usage against cancers and medicinal compositions containing it
07/26/2000CN1054851C 3-aryl-pyrone derivatives and their preparing methods and uses as pesticides and herbicides
07/26/2000CN1054844C N-substituted azabicycloheptane derivatives, their preparation and use
07/26/2000CN1054842C 1-amidinophenyl-pyrrolidones piperidinones azetinones platelet aggregation inhibitors
07/25/2000US6093812 Process for the stereospecific synthesis of azetidinones
07/25/2000US6093735 Selective β-3 adrenergic agonists
07/25/2000US6093734 Pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs having a hydrolyzable sulfinyl or arylsulfonyl group attached to the benzimidazole nitrogen; gastrointestinal disorders
07/25/2000US6093732 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
07/25/2000US6093718 An oxido-squalene cyclase inhibitor, anticholesterol agent for inhibiting cholesterol biosynthesis and lowering cholesterol levels in blood plasma; treating hypercholesterolemia and atherosclerosis
07/25/2000CA2272597A1 Quaternary ammonium salts of sulfonylurea
07/25/2000CA2169115C 1-¬2-(substituted vinyl)|-5h-2,3-benzodiazepine derivatives
07/20/2000WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000WO2000042026A1 Non-peptide glp-1 agonists
07/20/2000WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity
07/20/2000WO2000041992A1 Reductive alkylation of secondary amines with hydrosilane
07/20/2000WO2000014064A3 Gaba uptake inhibitors having a pyrrolidine structure
07/20/2000WO2000001687A9 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
07/20/2000WO1999000373A8 Benzimidazole derivatives
07/20/2000CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity
07/20/2000CA2359569A1 Reductive alkylation of secondary amines with hydrosilane
07/20/2000CA2359416A1 6-arylphenanthridines with pde-iv inhibiting activity
07/19/2000EP1020453A1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid deri vatives, addition salts thereof, and processes for the preparation of both
07/19/2000EP1020452A1 Benzimidazole derivatives
07/19/2000EP1020445A1 Fused pyridine derivatives